Results 1 - 10 of 1095
Search results for: Text "Extended release" - all of the words/ (Protocol search)
Sort results by:
per page
 |
Free |  |
Subscribed |  |
Trial |
Pub. Date:
Mar-07-2008;
DOI:10.1007/978-1-59745-210-6_11
Summary: Extended-Release Oral Drug Delivery Technologies: Monolithic Matrix Systems Oral drug delivery is the largest and the oldest segment of the total drug delivery market. It is the fastest growing...
 |
Pub. Date:
Aug-12-1987;
DOI:10.1385/0-89603-105-5:113
Summary: chromatographic or electrophoretic separations are frequently required in the identification and measurement of neuropeptides, the controls and precautions indicated above should be extended to these preparative...
|
Pub. Date:
Feb-15-2002;
DOI:10.1385/1-59259-169-8:819
Summary: O-Linked Oligosaccharide Profiling by HPLC The several different core regions of O-linked chains (
Chapter 113
) can be further extended by Gal...
|
Pub. Date:
July-11-1996;
DOI:10.1007/978-1-60327-259-9_106
Summary: O-Linked Oligosaccharide Profiling by HPLC The several different core regions of O-linked chains (Chapter 105) can be further extended by Gal and GlcNAc containing backbones or by addition of blood...
|
Year:
2009;
DOI:10.1007/978-1-59745-198-7_134
Summary: O-Linked Oligosaccharide Profiling by HPLC The several different core regions of O-linked chains (Chapter 133) can be further extended by Gal and GlcNAc containing backbones or by addition of blood...
|
Pub. Date:
Jan-14-2003;
DOI:10.1385/1-59259-294-5:27
Summary: oligosaccharides are quite variable in structure and are often extended with additional sugars (23–25) and therefore the use of the current so-called “O-glycanase” is of very...
|
Pub. Date:
Apr-13-2000;
DOI:10.1385/1-59259-058-6:157
Summary: in the density of the two Percoll solutions is ~1% so small differences will affect the results. We have also noted that leaving the blood at room temperature for any extended time before adding...
|
Pub. Date:
Mar-07-2008;
DOI:10.1007/978-1-59745-210-6_1
Summary: or a device that enables the introduction of a therapeutic substance in the body and improves its efficacy and safety by controlling the rate, time, and place of release of drugs in the body. This process...
|
Pub. Date:
Feb-26-2007;
DOI:10.1007/978-1-59745-277-9_15
Summary: for consistently low specific release of susceptible targets include not promptly removing mononuclear cells from Ficoll-Hypaque, extended incubation times in RBC lysing buffer, incubation of microtiter...
|
Pub. Date:
Aug-09-2001;
DOI:10.1385/1-59259-139-6:195
Summary: , or to occur over an extended period of time; thus, a delivery system can be tailored to a particular application. For bolus delivery, drug levels quickly rise and decline as the drug is cleared...
Sort results by:
per page
Results 1 - 10 of 1095